Bharat Biotech gets DCGI nod to test nasal COVID-19 vaccine as booster shot

Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday got 'in principle' approval from the country's drug regulator to test nasal COVID-19 vaccine as a booster shot.

Advertisment

1/38

2/38

3/38

4/38

5/38

6/38

7/38

8/38

9/38

10/38

11/38

12/38

13/38

14/38

15/38

16/38

17/38

18/38

19/38

20/38

21/38

22/38

23/38

24/38

25/38

26/38

27/38

28/38

29/38

30/38

31/38

32/38

33/38

34/38

35/38

36/38

37/38

38/38

India's drug regulator DCGI on Wednesday granted approval to Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to news sources.

According to reports, DCGI's Subject Expert Committee (SEC) has granted 'in principle' approval to Bharat Biotech for the conduct of 'Phase III superiority study & Phase III booster dose study' for its intranasal COVID vaccine.

The DCGI also directed the vaccine maker to submit protocols for approval.